The impact of the contraceptive medication-induced change in hormonal levels on the vaginal microbiome.
Rentschler Biopharma contributes to nearly 25% of FDA approved biopharmaceuticals in 2023 – Biotech Investments
EQS-News: Rentschler Biopharma SE / Key word(s): Regulatory Approval Rentschler Biopharma contributes to nearly 25% of FDA approved biopharmaceuticals in 2023 06.03.2024 / 10:00 CET/CEST